Authors
Loading...
Randomized double-blind trial finds potential symptomatic benefit from cannabidiol extract in ulcerative colitis, suggesting therapeutic value despite an unmet primary endpoint.
Irving et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: